TENO-VAXIN

Poultry

Therapeutic Class

Sub-species

Teno-Vaxin®

Pharmaceutical Name
Tenosynovitis (Viral Arthritis) Vaccine -- Live reovirus strain S-1133, chicken embryo origin


Features and Benefits

  • Approved for use via drinking water

  • Stimulates strong immune response

  • Ensures maximum response to revaccination with inactivated reovirus vaccines

  • Ability to spread bird-to-bird ensures uniform flock protection

  • Contains gentamicin as a preservative 

Indications
For vaccination of healthy chickens 10 to 17 weeks of age as an aid in control and prevention of reovirus-induced tenosynovitis (viral arthritis) in broiler breeders. 
 
Dosage
For further information including dose rate and complete directions and warnings, please see the Product Label by clicking here.
 
Teno-Vaxin® is a registered trademark of Schering-Plough Animal Health Corporation.